Affected individuals harbor mutations to any one of the three genes encoding the type IV collagen network found in mature GBM; COL4A3, COL4A4, or COL4A5, and Alport patients usually suffer a progressive loss of barrier function, splitting of the GBM, and, eventually, renal failure [3]. This evidence concerns the gene COL4A4 and kidney failure.